Equity Details
Price & Market Data
Price: $29.85
Daily Change: +$0.01 / 0.03%
Daily Range: $29.31 - $30.11
Market Cap: $812,859,392
Daily Volume: 247,031
Performance Metrics
1 Week: -2.21%
1 Month: 14.05%
3 Months: 95.33%
6 Months: 75.80%
1 Year: 71.24%
YTD: 75.69%
About Eton Pharmaceuticals, Inc. (ETON)
Stock insights for Eton Pharmaceuticals, Inc. (ETON). Price: 29.85, daily change: +$0.01 / 0.03%. Market cap: 812,859,392. Performance 3-month, 6-month, 1-year.
Company Details
Employees: 44
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.